期刊文献+

GM_1对实验性脑缺血再灌注损伤的作用 被引量:2

The effects of monosidoltetrahexosylganglioside(GM_1) on experimental cerebral ischemia and reperfusion damage
下载PDF
导出
摘要 目的 研究单唾液酸四己糖神经节苷脂 (GM1 )对脑缺血再灌注损伤的作用。方法 采用大鼠全脑缺血再灌注动物模型(4VO) ,测定观察假手术组 (对照组 )、脑缺血 30 min再灌注 60 min生理盐水处理组、GM1 处理组脑海马组织线粒体钙 (MCa)、钙调素(Ca M)含量改变 ,以及缺血 30 min再灌注 4 d脑海马 CA1 区普通病理和超微病理改变。结果 脑缺血 30 min再灌注 60 min海马组织MCa、Ca M含量显著性升高 (P<0 .0 1 ) ,脑缺血 30 min再灌注 4d海马 CA1 区神经元呈现严重缺血、坏死病理改变 ,GM1 处理后则上述结果明显好转。结论  GM1 对脑缺血再灌注损伤具有保护作用。 o study the GM 1 effects on cerebral ischemia and reperfusion damage.Methods With global cerebral ischemia and reperfusion rat model(4VO),the hippocampic mitochondria calcium(MCa),calmodulin(CaM) contents at sham group,cerebral ischemia 30 min reperfusion 60 min group treated by normal saline(NS) and GM 1(10 mg/kg IP),were observed.and the pathologic changes of hippocampic CA 1 district after 4 days reperfusion followed 30 min ischemia GM 1 10 mg/kg IP,daily for 4 days were also studied.Results The hippocampic MCa,CaM contents were significantly higher on cerebral ischemia and reperfusion group than that in sham group( P <0 01),the hippocampic CA 1 district neuron showed obvious pathologic damage.The levels of MCa,CaM in GM 1 treated group were significantly lower than that of the control group with NS( P <0 01),and the pathologic changes were improved in GM 1 group.Conclusions GM 1 with cerebral protective effect on cerebral ischemia and reperfusion damage were confirmed.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2000年第6期361-364,389,共4页 Chinese Journal of Gerontology
关键词 GM1 线粒体钙 脑缺血 再灌注损伤 Monosidoltetrahexosylganglioside Mitochondria calcium Calmodulin Cerebral ischemia and reperfusion damage
  • 相关文献

参考文献2

  • 1刘景生 刘晔 等.钙调蛋白的制备及活性测定[J].中国医学科学院学报,1985,7(6):453-453.
  • 2刘景生,中国医学科学院学报,1985年,7卷,6期,453页

共引文献20

同被引文献39

  • 1陈劲草,毛捷,王胜,雷霆.神经节苷脂对大脑缺血再灌注损伤的保护作用[J].中华实验外科杂志,2004,21(5):583-585. 被引量:7
  • 2董强,董为伟,王伟,傅雅各.受体滥用依赖拮抗剂神经节苷脂对实验性脑缺血的保护作用[J].中风与神经疾病杂志,1993,10(4):193-196. 被引量:13
  • 3Nagai Y. Functional roles of gangliosides in bio-signaling [J]. Behav Brain Res, 1995, 66(1-2): 99-104.
  • 4Phillis JW, O'Regan MH. GM1 ganglioside inhibits ischemic release of amino acid neurotransmitters from rat cortex [J]. Neuroreport ,1995 , 6 (15) : 2010-2012.
  • 5Iwashjta A, Hisjima H, Notsu Y, et al. Effects of basic fibroblast growth factor and GM1 on survival in primary cultures and on eightarm radial maze task in adult rats following partial fimbria transsections [J]. Nauny Schmiedebergs Arch harmcol, 1996, 353 (3) : 342-348.
  • 6Duchemin AM, Neff NH, Hadjiconstantino M. GM1 increase the content and mRNA NGF in the brain of aged rats [J]. Neuroreport, 1997, 8 (17) : 3823-3827.
  • 7Jain KK. Neuroprotection in cerbrovascular disease [J]. Expert Op in Investig Drugs, 2000, 9 (4) : 695-711.
  • 8Barth A, Barth L, Newell DW. Combination therapy of MK-801 and a-phenyltert-buty1-nitrone enhances protection against isehemic neuronal damage in organotypic hippocampal slice cultures[J]. Exp Neurol, 1996, 141 (2) : 330-336.
  • 9Grahan SH , Chen J , Sharp FR. et al . Limiting ischemic injury by inhibition of excitatory amino acid release [J]. J Cereb Blood Flow Metab , 1993 ,13 :88-97.
  • 10Simon RP, Chen J, Graham MS, et al. GM1 ganglioside treatment of focal ischemia: a dose response and microdialysis study [J]. J Pharmacol Exp Ther, 1993,165: 24-29.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部